Healthcare -
Biotechnology - NASDAQ - US
$ 21.7
2.12 %
$ 238 M
Market Cap
-0.91
P/E
Price Target
Average
10.60%
Revenue Forecast
Estimate
2.59%
EBIT
Estimate
--28.46%
Net Income
Estimate
8.19%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cidara Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for CDTX of $24 , with forecasts ranging from
a
low of
$24 to a high of $24 .
CDTX Lowest Price Target
Wall Street Target
24 USD
10.60%
CDTX Average Price Target
Wall Street Target
24 USD
10.60%
CDTX Highest Price Target
Wall Street Target
24 USD
10.60%
REVENUE FORECAST
Revenue Forecast Chart CDTX
EBIT FORECAST
EBIT Forecast Chart CDTX
NET INCOME FORECAST
Net Income Chart CDTX